Pharma-Bio Serv, Inc.

$0.57 0.00%(+$0.00)
TickerSpark Score
65/100
Solid
90
Valuation
50
Profitability
55
Growth
52
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PBSV research report →

52-Week Range15% of range
Low
$0.43
Current
$0.57
High
$1.36
Company Overviewwww.pharmabioserv.com

About the company

Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies.

CEO
Victor Sanchez
IPO
2007
Employees
75
HQ
Dorado, PR, US

Price Chart

-5.00% · this period
$0.69$0.58$0.46Jul 02Dec 31Jul 02
Valuation
Market Cap
$13.05M
P/E
-1.55
P/S
1.43
P/B
0.00
EV/EBITDA
-96.34
Div Yield
13.16%
Profitability
Gross Margin
32.35%
Op Margin
-4.36%
Net Margin
0.67%
ROE
0.00%
ROIC
-0.00%
Growth & Income
Revenue
$9.00M · -5.34%
Net Income
$-100,463 · 87.08%
EPS
$-0.00 · 87.02%
Op Income
$-637,662
FCF YoY
69.50%
Performance & Tape
52W High
$1.36
52W Low
$0.43
50D MA
$0.54
200D MA
$0.55
Beta
0.68
Avg Volume
624

Get TickerSpark's AI analysis on PBSV

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 10, 26MICHEL KIRK WHEELERother20,000
Jan 10, 26Perlysky Dovother20,000
Jan 10, 26SPINDEL HOWARDother20,000
Jan 10, 26WIESEN IRVING Lother20,000
Jan 10, 25MICHEL KIRK WHEELERother20,000
Jan 10, 25Perlysky Dovother20,000
Jan 10, 25SPINDEL HOWARDother20,000
Jan 10, 25WIESEN IRVING Lother20,000
Jan 10, 24Perlysky Dovother20,000
Jan 10, 24WIESEN IRVING Lother20,000
Coverage · PBSV

Our PBSV coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PBSV yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PBSV report →
Internal Compare

Similar companies

Peers in the same neighborhood.